Clinical Trials · NCT07476001
Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Enrollment
- 12
- Start date
- Mar 2026
- Locations
- 1 site, United States
- Primary endpoint
- Feasibility of Tc400 and PSMA-617